Stock VTVT VTV THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages vTv Therapeutics Inc.

Equities

VTVT

US9183852048

Market Closed - Nasdaq
Other stock markets
 21:30:01 06/05/2024 BST 		5-day change 1st Jan Change
24.7 USD +4.53% Intraday chart for vTv Therapeutics Inc. -12.35% +114.78%
03-14 VTv Therapeutics Inc. Announces Board Changes CI
03-13 VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
VTv Therapeutics Inc. Announces Board Changes
VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
VTv Therapeutics Inc. Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
Top Midday Gainers
VTv Therapeutics Inc. Announces Board Changes
Vtv Therapeutics Inc. Announces Resignation of Chandresh Harjivan as Member of the Board of Directors
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Vtv Therapeutics Inc. Appoints Thomas Strack, M.D., as Chief Medical Officer
VTv Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
VTv Therapeutics Says Cantex Pharmaceuticals Received IP License for Azeliragon
Cantex Pharmaceuticals Receives US Patent Covering vTv Therapeutics' Azeliragon
VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
VTv Therapeutics Inc. Auditor Raises 'Going Concern' Doubt
VTv Therapeutics Inc. Appoints Elizabeth Keiley as Executive Vice President and General Counsel
VTv Therapeutics Names Steven Tuch Finance Chief
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
VTv Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VTVT Stock
  4. News vTv Therapeutics Inc.
  5. Other languages